NCT05776836View on ClinicalTrials.gov

Evaluation of HA Dermal Fillers in the Treatment of Pathological Facial Lipoatrophy

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 28, 2023

Primary Completion Date

December 13, 2023

Study Completion Date

November 26, 2024

Conditions
Facial Lipoatrophy (FLA)
Interventions
DEVICE

Dermal filler

Subjects will be consecutively included to receive FASY F in nasolabial folds and cheeks and FASY P in periorbital areas.

Trial Locations (3)

69006

Palais de Flore, Lyon

75116

THINKIN, Paris

94100

Dermatology practice, Saint-Maur-des-Fossés

All Listed Sponsors
collaborator

EVAMED

OTHER

lead

Symatese

INDUSTRY

NCT05776836 - Evaluation of HA Dermal Fillers in the Treatment of Pathological Facial Lipoatrophy | Biotech Hunter | Biotech Hunter